InsidersTradesSigma
Explore the complete record of transactions filed by 박창익, Chief Executive Officer. Insider active across 2 companies, notably 삼진제약. Aggregated, 1 reports have been logged. The latest transaction was disclosed on 13 April 2026 — Purchase. Regulator: DART (FSS). All data is accessible without signup.
1 of 1 declaration
Park Chang-ik is the Executive Director at 삼진제약, a pharmaceutical company. In this role, he is responsible for managing operations and implementing the company's strategies. His leadership is essential for the development and growth of 삼진제약.